Jubilant Biosys, Mnemosyne enter into research collaboration
As per the alliance agreement, Mnemosyne will own all IP generated and is responsible for clinical development and commercialization. The collaboration is expected to focus on developing subunit
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.